Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer

類似資料

• Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma
  著者:: Baba, Yuh, 等
  出版事項: (2017)
• Deguelin Induces Apoptosis by Targeting Both EGFR-Akt and IGF1R-Akt Pathways in Head and Neck Squamous Cell Cancer Cell Lines
  著者:: Yuh Baba, 等
  出版事項: (2015-01-01)
• Deguelin Induces Apoptosis by Targeting Both EGFR-Akt and IGF1R-Akt Pathways in Head and Neck Squamous Cell Cancer Cell Lines
  著者:: Baba, Yuh, 等
  出版事項: (2015)
• Preclinical modeling of EGFR inhibitor resistance in head and neck cancer
  著者:: Quesnelle, Kelly M., 等
  出版事項: (2012)
• Clinicopathological Significance of Expression of CD44 Variants in Head and Neck Squamous Cell Carcinoma
  著者:: Kanke, Minoru, 等
  出版事項: (2000)